NewcelX Ltd. (NCEL) Stock Ticker
Market factors today
Unlock the full NCEL picture
About NewcelX Ltd.
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
NCEL stock facts
| Ticker symbol | NCEL |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.3M |
| CEO | Ronen Twito |
| Employees | 11 |
| Headquarters | Kloten, ZH, CH |
| IPO date | 2025-10-24 |
| Website | newcelx.net |
What you can see for NCEL on Tickr
Live NCEL price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NCEL report.
Rankings
FAQ
What is the ticker symbol for NewcelX Ltd.?
The ticker symbol for NewcelX Ltd. is NCEL, listed on the NASDAQ Capital Market.
What is NCEL?
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.